HKEX: 3692 - Hansoh Pharmaceutical Group Company Limited

Rentabilidade por seis meses: +3.13%
Rendimento de dividendos: +2.02%
Setor: Healthcare

Cronograma de promoção Hansoh Pharmaceutical Group Company Limited


Sobre a empresa Hansoh Pharmaceutical Group Company Limited

Hansoh Pharmaceutical Group Company Limited, инвестиционная холдинговая компания, занимается исследованием, разработкой, производством и продажей фармацевтической продукции в Китайской Народной Республике. Компания предоставляет продукты для терапевтических областей, в том числе противоопухолевых, противоинфекционных, заболеваний центральной нервной системы, метаболических заболеваний и других терапевтических областей.

mais detalhes
Его основные продукты включают препараты Mailingda, Ameile, Hansoh Xinfu, Fulaimei, Hengmu, Xinwei, Tanneng, Ameining, Oulanning, Ailanning, Zetan, Ruibote, Fulaidi, Puruian, Fulairui, Pulaile, Zefei, Xinmei, Xintai и Gainuo, а также СИНЬЮЭ и Хенгсен. Компания обслуживает дистрибьюторов фармацевтической продукции. Он сотрудничает с NiKang Therapeutics для разработки и коммерциализации NKT2152; TiumBio для разработки и коммерциализации TU2670 для лечения эндометриоза, миомы матки и других показаний; Глобальный институт медицинских открытий для разработки, производства и коммерциализации серии GDI-4405 против нового коронавируса; KiOmed Pharma SA для разработки и коммерциализации KiOmedinevsOne для лечения остеоартрита; и Biotheus Inc. для разработки и коммерциализации PM1080. Компания была основана в 1995 году и имеет штаб-квартиру в Шанхае, Китайская Народная Республика. Hansoh Pharmaceutical Group Company Limited является дочерней компанией Stellar Infinity Company Ltd.
Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

ISIN KYG549581067
Industry Pharmaceuticals
Sector Health Care
Валюта hkd
Валюта отчета cny
Див.доход ао 2.31
Дивиденд ао 0.3432
Сайт https://www.hspharm.com
Цена ао 17.14
Alteração de preço por dia: +1.78% (16.84)
Alteração de preço por semana: +5.41% (16.26)
Alteração de preço por mês: -6.54% (18.34)
Alteração de preço em 3 meses: -19.15% (21.2)
Mudança de preço em seis meses: +3.13% (16.62)
Mudança de preço por ano: +48.27% (11.56)
Mudança de preço em 3 anos: -8.54% (18.74)
Mudança de preço em 5 anos: -25.8% (23.1)
Mudança de preço em 10 anos: 0% (17.14)
Mudança de preço desde o início do ano: -7.25% (18.48)
Todos os parâmetros

Subestimação

Nome Significado Nota
P/S 7.55 1
P/BV 2.96 6
P/E 23.28 6
EV/EBITDA 25.04 4
Total: 5.75

Eficiência

Nome Significado Nota
ROA, % 10.4 4
ROE, % 13.53 4
Total: 4.33

Dividendos

Nome Significado Nota
Div yield, % 2.02 5.05
DSI 1 10
Total: 6.14

Obrigação

Nome Significado Nota
Debt/EBITDA 1.31 8
Total: 8.8

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % 16.37 3
Rentabilidade Ebitda, % 45.16 6
Rentabilidade EPS, % 1074.7 10
Total: 4.8
Mais detalhes

Instituições Volume Compartilhar, %
Fidelity Advisor Focused Emerging Markets Fund 34306000 0.58
Fidelity Strategic Advisors Fidelity Emerging Markets Fund 17134000 0.29
Vanguard International Stock Index-Emerging Markets Stk 13235000 0.22
Vanguard International Stock Index-Total Intl Stock Indx 13095836 0.22
Fidelity Series Emerging Markets Opportunities Fund 10250000 0.17
iShares Core MSCI Emerging Markets ETF 10204000 0.17
Fidelity VIP Emerging Markets Portfolio 9078000 0.15
Fidelity Strategic Advisers Emerging Markets Fund 7653744 0.13
Fidelity Emerging Markets Discovery Fund 7410308 0.12
iShares MSCI China ETF 3556000 0.06

ETF Compartilhar, % Rentabilidade para o ano, % Dividendos, %
Loncar China BioPharma ETF 2.19 18434.25
KraneShares MSCI All China Health Care Index ETF 1.58339 15.16 2.31691
Global X Aging Population ETF 1.24142 20.37 1.46713
FlexShares International Quality Dividend Dynamic Index Fund 0.82555 12.66 5.93365
Nuveen ESG Emerging Markets Equity ETF 0.31255 11.62 2.89278
Avantis Emerging Markets Value ETF 0.26556 14.12 4.22231
WisdomTree China ex-State-Owned Enterprises Fund 0.23369 13.84 2.29363
Franklin FTSE China ETF 0.13013 14.5 3.35323
FINEX CHINA UCITS ETF 0.13 -34.73
SPDR S&P China ETF 0.10157 17.02 3.40103
Xtrackers MSCI Emerging Markets ESG Leaders Equity ETF 0.07086 17.59 2.86877
SPDR MSCI Emerging Markets Fossil Fuel Free ETF 0.05765 14.02 2.84808
Avantis Emerging Markets Equity ETF 0.05491 8.77 3.60513
Goldman Sachs ActiveBeta Emerging Markets Equity ETF 0.04687 9.13 3.47133
Xtrackers MSCI Emerging Markets Hedged Equity ETF 0.0409 15.84 3.04307
John Hancock Multifactor Emerging Markets ETF 0.03921 4.68 3.42078
Avantis Responsible Emerging Markets Equity ETF 0.03118 17.6 3.1719
Franklin FTSE Asia ex Japan ETF 0.0274 14.43 2.66768
SPDR MSCI ACWI Climate Paris Aligned ETF 0.01526 25.32 1.86415
Dimensional Emerging Markets Core Equity 2 ETF 0.01498 15.96 3.34087
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund 0.01317 12.46 3.59676
SPDR Portfolio Emerging Markets ETF 0.01297 11.59 3.1879
Xtrackers MSCI All World ex US Hedged Equity ETF 0.01273 18.18 3.26685
Vanguard ESG International Stock ETF 0.01 6.39 3.07501
iShares MSCI ACWI ETF 0.00442 -19.68 2.10908
Dimensional International Small Cap ETF 0.00439 5.69 3.34747
Dimensional World ex U.S. Core Equity 2 ETF 0.00216 13.06 3.62488
Dimensional International Core Equity Market ETF 0.00035 13.09 3.48343



Supervisor Cargo Pagamento Ano de nascimento
Ms. Huijuan Zhong Chairlady, CEO & President 12.07M 1961 (64 ano)
Mr. Min Hu VP & CFO N/A 1977 (48 anos)
Ms. Yuan Sun Executive Director 7.43M 1987 (38 anos)
Mr. Chuanhe Xu Senior Vice President N/A 1964 (61 ano)
Mr. Weiyong Sun Chief Commercial Officer N/A 1971 (54 ano)
Dr. Aifeng Lyu Executive Director 1977 (48 anos)
Dr. Chih-Hung Lee Chief of Science Officer 1960 (65 anos)
Ms. Shengli Zhong Joint Company Secretary & Senior VP 1968 (57 anos)
Ms. Sze Wai Tam Joint Company Secretary

Endereço: China, Shanghai, 287 Xiangke Road - abrir no Google Maps, abrir mapas Yandex
Site: https://www.hspharm.com